✦ LIBER ✦

Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system

✍ Scribed by Marc A.T Teunis; Cobi J Heijnen; Alexander R Cools; Annemieke Kavelaars

Book ID: 113866868
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 129 KB
Volume: 29
Category: Article
ISSN: 0306-4530
DOI: 10.1016/j.psyneuen.2003.09.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced natural killer cell activity in

Reduced natural killer cell activity in patients with systemic sclerosis

✍ Edward B. Miller; John C. Hiserodt; Laverne E. Hunt; Virginia D. Steen; Thomas A 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB

Reduced natural killer cell activity in

Reduced natural killer cell activity in gluten-sensitive enteropathy

✍ P. A. DREW; P. A. S. HETZEL; J. SMITH 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

The biphasic changes in splenic natural

The biphasic changes in splenic natural killer cell activity following ventromedial hypothalamic lesions in rats

✍ Toshihiko Katafuchi; Eiichiro Okada; Sachiko Take; Tetsuro Hori 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Natural killer cell activity is reduced

Natural killer cell activity is reduced in association with oral contraceptive use

✍ James M. Scanlan; James J. Werner; Rebecca L. Legg; Mark L. Laudenslager 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Splenic natural killer cell activity in

Splenic natural killer cell activity in two models of experimental neurodegenerative diseases

✍ Yassin Al-Falahi; Kristin L. Sand; Eirunn Knudsen; Bassam B. Damaj; Johannes Rol 📂 Article 📅 2008 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 987 KB

Lymphokine-activated killer cell and nat

Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis

✍ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr